Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Talphera, Inc. (TLPH) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Talphera, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1427925.
Total stock buying since 2011: $52,686,923.
Total stock sales since 2011: $22,674,590.
Total stock option exercises since 2011: $152,240.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 32,955 | $30,342 | 155 | $118 | 0 | $0 |
| 2023 | 20,000 | $15,220 | 16,956 | $19,235 | 0 | $0 |
| 2022 | 46,400 | $10,347 | 0 | $0 | 0 | $0 |
| 2020 | 107,547 | $138,936 | 0 | $0 | 0 | $0 |
| 2019 | 92,988 | $218,703 | 0 | $0 | 0 | $0 |
| 2018 | 127,610 | $369,085 | 40,520 | $199,123 | 0 | $0 |
| 2017 | 72,000 | $178,978 | 898,988 | $2,153,751 | 37,500 | $45,000 |
| 2016 | 25,206 | $80,521 | 609,350 | $2,294,466 | 0 | $0 |
| 2015 | 75,400 | $125,120 | 578,300 | $2,661,083 | 54,000 | $107,240 |
| 2014 | 1,000 | $10,300 | 1,000,000 | $12,329,370 | 0 | $0 |
| 2013 | 1,650,660 | $15,452,677 | 286,933 | $3,017,444 | 0 | $0 |
| 2012 | 2,986,314 | $9,935,944 | 0 | $0 | 0 | $0 |
| 2011 | 5,250,822 | $26,120,750 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 5,000 | $3,200 | 155 | $118 | 0 | $0 |
| 2024-11 | 5,000 | $3,650 | 0 | $0 | 0 | $0 |
| 2024-08 | 7,260 | $7,601 | 0 | $0 | 0 | $0 |
| 2024-06 | 15,695 | $15,891 | 0 | $0 | 0 | $0 |
| 2023-12 | 10,000 | $7,270 | 0 | $0 | 0 | $0 |
| 2023-09 | 10,000 | $7,950 | 0 | $0 | 0 | $0 |
| 2023-08 | 0 | $0 | 16,956 | $19,235 | 0 | $0 |
| 2022-06 | 46,400 | $10,347 | 0 | $0 | 0 | $0 |
| 2020-06 | 107,547 | $138,936 | 0 | $0 | 0 | $0 |
| 2019-11 | 33,379 | $59,548 | 0 | $0 | 0 | $0 |
| 2019-08 | 15,000 | $32,810 | 0 | $0 | 0 | $0 |
| 2019-06 | 5,000 | $11,550 | 0 | $0 | 0 | $0 |
| 2019-03 | 19,000 | $56,886 | 0 | $0 | 0 | $0 |
| 2019-02 | 20,609 | $57,909 | 0 | $0 | 0 | $0 |
| 2018-12 | 18,610 | $53,799 | 0 | $0 | 0 | $0 |
| 2018-11 | 41,700 | $123,139 | 0 | $0 | 0 | $0 |
| 2018-10 | 0 | $0 | 33,567 | $167,835 | 0 | $0 |
| 2018-09 | 0 | $0 | 6,953 | $31,288 | 0 | $0 |
| 2018-08 | 57,300 | $159,487 | 0 | $0 | 0 | $0 |
| 2018-06 | 5,000 | $16,735 | 0 | $0 | 0 | $0 |
| 2018-05 | 5,000 | $15,925 | 0 | $0 | 0 | $0 |
| 2017-11 | 35,000 | $66,680 | 0 | $0 | 0 | $0 |
| 2017-10 | 0 | $0 | 10,161 | $53,751 | 37,500 | $45,000 |
| 2017-09 | 7,000 | $22,708 | 13,827 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-05 | Angotti Vincent J. (CHIEF EXECUTIVE OFFICER) | Buy | 5,000 | .64 | 3,200 |
| 2024-12-02 | Asadorian Raffi (Chief Financial Officer) | Sale | 155 | .77 | 118 |
| 2024-11-27 | Angotti Vincent J. (CHIEF EXECUTIVE OFFICER) | Buy | 5,000 | .73 | 3,650 |
| 2024-08-30 | Angotti Vincent J. (CHIEF EXECUTIVE OFFICER) | Buy | 7,260 | 1.05 | 7,601 |
| 2024-06-14 | Aslam Shakil (Chief Medical Officer) | Buy | 5,000 | 1.07 | 5,355 |
| 2024-06-14 | Angotti Vincent J. (CHIEF EXECUTIVE OFFICER) | Buy | 1,304 | 1.08 | 1,404 |
| 2024-06-13 | Aslam Shakil (Chief Medical Officer) | Buy | 695 | .98 | 681 |
| 2024-06-13 | Angotti Vincent J. (CHIEF EXECUTIVE OFFICER) | Buy | 4,570 | .97 | 4,437 |
| 2024-06-12 | Angotti Vincent J. (CHIEF EXECUTIVE OFFICER) | Buy | 4,126 | .97 | 4,014 |
| 2023-12-13 | Angotti Vincent J. (Chief Executive Officer) | Buy | 10,000 | .73 | 7,270 |
| 2023-09-11 | Angotti Vincent J. (Chief Executive Officer) | Buy | 10,000 | .80 | 7,950 |
| 2023-08-25 | Palmer Pamela P (Chief Medical Officer) | Sale | 7,442 | 1.09 | 8,104 |
| 2023-08-24 | Palmer Pamela P (Chief Medical Officer) | Sale | 9,514 | 1.17 | 11,131 |
| 2022-06-07 | Angotti Vincent J. (Chief Executive Officer) | Buy | 46,400 | .22 | 10,347 |
| 2020-06-15 | Angotti Vincent J. (Chief Executive Officer) | Buy | 7,547 | 1.33 | 10,037 |
| 2020-06-15 | Adams Adrian (Director) | Buy | 100,000 | 1.29 | 128,899 |
| 2019-11-12 | Edwards Mark G (Director) | Buy | 25,000 | 1.78 | 44,575 |
| 2019-11-11 | Angotti Vincent J. (Chief Executive Officer) | Buy | 8,379 | 1.79 | 14,973 |
| 2019-08-26 | Edwards Mark G (Director) | Buy | 5,000 | 2.17 | 10,850 |
| 2019-08-23 | Edwards Mark G (Director) | Buy | 10,000 | 2.20 | 21,960 |
| 2019-06-05 | Angotti Vincent J. (Chief Executive Officer) | Buy | 5,000 | 2.31 | 11,550 |
| 2019-03-12 | Edwards Mark G (Director) | Buy | 19,000 | 2.99 | 56,886 |
| 2019-02-28 | Angotti Vincent J. (Chief Executive Officer) | Buy | 3,234 | 2.81 | 9,087 |
| 2019-02-28 | Asadorian Raffi (Chief Financial Officer) | Buy | 3,647 | 2.81 | 10,248 |
| 2019-02-28 | Hamel Lawrence G (Chief Development Officer) | Buy | 3,682 | 2.81 | 10,346 |
| 2019-02-28 | Palmer Pamela P (Chief Medical Officer) | Buy | 840 | 2.81 | 2,360 |
| 2019-02-28 | Dasu Badri N (Chief Engineering Officer) | Buy | 9,206 | 2.81 | 25,868 |
| 2018-12-14 | Angotti Vincent J. (Chief Executive Officer) | Buy | 3,610 | 2.78 | 10,024 |
| 2018-12-14 | Asadorian Raffi (Chief Financial Officer) | Buy | 5,000 | 2.78 | 13,885 |
| 2018-12-12 | Angotti Vincent J. (Chief Executive Officer) | Buy | 10,000 | 2.99 | 29,890 |
| 2018-11-19 | Palmer Pamela P (Chief Medical Officer) | Buy | 16,000 | 3.07 | 49,120 |
| 2018-11-15 | Edwards Mark G (Director) | Buy | 20,700 | 2.82 | 58,374 |
| 2018-11-13 | Asadorian Raffi (Chief Financial Officer) | Buy | 5,000 | 3.13 | 15,645 |
| 2018-10-15 | Hamel Lawrence G (Chief Development Officer) | Sale | 5,216 | 5.00 | 26,080 |
| 2018-10-15 | Dasu Badri N (Chief Engineering Officer) | Sale | 28,351 | 5.00 | 141,755 |
| 2018-09-24 | Hamel Lawrence G (Chief Development Officer) | Sale | 6,953 | 4.50 | 31,288 |
| 2018-08-07 | Angotti Vincent J. (Chief Executive Officer) | Buy | 10,000 | 2.90 | 28,950 |
| 2018-08-07 | Edwards Mark G (Director) | Buy | 5,300 | 2.84 | 15,062 |
| 2018-08-06 | Asadorian Raffi (Chief Financial Officer) | Buy | 5,000 | 2.75 | 13,725 |
| 2018-08-06 | Palmer Pamela P (Chief Medical Officer) | Buy | 37,000 | 2.75 | 101,750 |
| 2018-06-05 | Edwards Mark G (Director) | Buy | 4,700 | 3.35 | 15,745 |
| 2018-06-01 | Edwards Mark G (Director) | Buy | 300 | 3.30 | 990 |
| 2018-05-25 | Asadorian Raffi (Chief Financial Officer) | Buy | 5,000 | 3.19 | 15,925 |
| 2017-11-14 | Edwards Mark G (Director) | Buy | 30,000 | 1.90 | 56,970 |
| 2017-11-13 | Asadorian Raffi (Chief Financial Officer) | Buy | 5,000 | 1.94 | 9,710 |
| 2017-10-19 | Dasu Badri N (Chief Engineering Officer) | Option Ex | 37,500 | 1.20 | 45,000 |
| 2017-10-02 | Hamel Lawrence G (Chief Development Officer) | Sale | 10,161 | 5.29 | 53,751 |
| 2017-09-25 | Hamel Lawrence G (Chief Development Officer) | Sale | 13,827 | .00 | 0 |
| 2017-09-11 | Asadorian Raffi (Chief Financial Officer) | Buy | 7,000 | 3.24 | 22,708 |
| 2017-08-24 | Angotti Vincent J. (Chief Executive Officer) | Buy | 15,000 | 3.00 | 45,000 |
| 2017-08-24 | Edwards Mark G (Director) | Buy | 4,800 | 3.02 | 14,520 |
| 2017-08-22 | Palmer Pamela P (Chief Medical Officer) | Buy | 10,000 | 2.95 | 29,490 |
| 2017-08-22 | Edwards Mark G (Director) | Buy | 200 | 2.90 | 580 |
| 2017-06-19 | Edelman Joseph (10% Owner) | Sale | 875,000 | 2.40 | 2,100,000 |
| 2016-09-29 | Perceptive Life Sciences Master Fund Ltd | Sale | 97,200 | 3.88 | 377,136 |
| 2016-09-28 | Perceptive Life Sciences Master Fund Ltd | Sale | 119,300 | 3.96 | 472,428 |
| 2016-09-15 | Perceptive Life Sciences Master Fund Ltd | Sale | 392,850 | 3.68 | 1,444,902 |
| 2016-05-13 | Rosen Howard B (CEO) | Buy | 10,206 | 3.26 | 33,271 |
| 2016-05-12 | Edwards Mark G (Director) | Buy | 5,000 | 3.05 | 15,250 |
| 2016-05-11 | Edwards Mark G (Director) | Buy | 5,000 | 3.15 | 15,750 |
| 2016-05-10 | Edwards Mark G (Director) | Buy | 5,000 | 3.25 | 16,250 |
| 2015-11-18 | Perceptive Life Sciences Master Fund Ltd | Sale | 42,300 | 5.35 | 226,135 |
| 2015-11-17 | Perceptive Life Sciences Master Fund Ltd | Sale | 133,900 | 5.36 | 717,436 |
| 2015-11-06 | Perceptive Life Sciences Master Fund Ltd | Sale | 17,100 | 4.47 | 76,368 |
| 2015-11-05 | Perceptive Life Sciences Master Fund Ltd | Sale | 75,000 | 4.62 | 346,275 |
| 2015-09-09 | Perceptive Life Sciences Master Fund Ltd | Sale | 310,000 | 4.18 | 1,294,869 |
| 2015-08-20 | Palmer Pamela P (Chief Medical Officer) | Option Ex | 29,000 | 2.56 | 74,240 |
| 2015-05-19 | Rosen Howard B (Intermin CEO) | Buy | 35,400 | .00 | 0 |
| 2015-05-07 | Edwards Mark G (Director) | Buy | 40,000 | 3.13 | 125,120 |
| 2015-03-12 | Palmer Pamela P (Chief Medical Officer) | Option Ex | 25,000 | 1.32 | 33,000 |
| 2014-06-23 | Afable Richard (Director) | Buy | 1,000 | 10.30 | 10,300 |
| 2014-03-10 | Wan Mark A (Director) | Sale | 835,327 | 12.36 | 10,324,641 |
| 2014-03-07 | Wan Mark A (Director) | Sale | 164,673 | 12.17 | 2,004,729 |
| 2013-11-07 | Perceptive Life Sciences Master Fund Ltd | Buy | 100,000 | 6.50 | 649,800 |
| 2013-11-06 | Perceptive Life Sciences Master Fund Ltd | Buy | 100,000 | 6.52 | 651,700 |
| 2013-11-04 | Perceptive Life Sciences Master Fund Ltd | Buy | 155,000 | 6.86 | 1,063,145 |
| 2013-11-01 | Perceptive Life Sciences Master Fund Ltd | Buy | 160,660 | 7.17 | 1,151,932 |
| 2013-10-31 | Perceptive Life Sciences Master Fund Ltd | Buy | 200,000 | 6.69 | 1,338,600 |
| 2013-09-20 | Nohra Guy P (Director) | Sale | 96,519 | 10.84 | 1,046,169 |
| 2013-09-19 | Nohra Guy P (Director) | Sale | 61,634 | 10.21 | 629,468 |
| 2013-09-18 | Nohra Guy P (Director) | Sale | 62,461 | 10.29 | 642,473 |
| 2013-09-17 | Nohra Guy P (Director) | Sale | 49,921 | 10.48 | 523,122 |
| 2013-09-16 | Nohra Guy P (Director) | Sale | 16,398 | 10.75 | 176,212 |
| 2013-07-23 | Perceptive Life Sciences Master Fund Ltd | Buy | 850,000 | 11.65 | 9,902,500 |
| 2013-06-06 | Edwards Mark G (Director) | Buy | 10,000 | 8.10 | 81,000 |
| 2013-05-28 | Adams Adrian (Director) | Buy | 50,000 | 8.39 | 419,500 |
| 2013-05-24 | Adams Adrian (Director) | Buy | 25,000 | 7.78 | 194,500 |
| 2012-12-07 | Three Arch Associates Iv Lp (10% Owner) | Buy | 2,416,918 | 3.31 | 7,999,998 |
| 2012-05-29 | Freund John Gordon (10% Owner) | Buy | 284,698 | 3.40 | 967,973 |
| 2012-05-29 | Three Arch Associates L P (10% Owner) | Buy | 284,698 | 3.40 | 967,973 |
| 2011-12-01 | Edwards Mark G (Director) | Buy | 10,000 | 2.79 | 27,900 |
| 2011-11-14 | Edwards Mark G (Director) | Buy | 40,000 | 2.90 | 116,000 |
| 2011-09-07 | Welch James H (Chief Financial Officer) | Buy | 3,000 | 3.39 | 10,179 |
| 2011-09-06 | Welch James H (Chief Financial Officer) | Buy | 7,000 | 3.32 | 23,240 |
| 2011-08-29 | Schreck Thomas A (Director) | Buy | 1,000 | 3.27 | 3,274 |
| 2011-08-24 | Schreck Thomas A (Director) | Buy | 2,000 | 3.01 | 6,020 |
| 2011-06-09 | Palmer Pamela P (Chief Medical Officer) | Buy | 8,800 | 4.61 | 40,568 |
| 2011-06-09 | King Richard (Chief Executive Officer) | Buy | 3,500 | 4.56 | 15,959 |
| 2011-02-16 | Freund John Gordon (10% Owner) | Buy | 1,235,943 | 5.00 | 6,179,715 |
| 2011-02-16 | Acmp Iv Llc (10% Owner) | Buy | 680,000 | 5.00 | 3,400,000 |
| 2011-02-16 | Three Arch Partners Iv Lp (10% Owner) | Buy | 1,289,790 | 5.00 | 6,448,950 |
| 2011-02-16 | Nohra Guy P (Director) | Buy | 680,000 | 5.00 | 3,400,000 |
| 2011-02-16 | Three Arch Associates Iii Lp (10% Owner) | Buy | 1,289,789 | 5.00 | 6,448,945 |
Insider trading activities including stock purchases, stock sales, and option exercises of TLPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Talphera, Inc. (symbol TLPH, CIK number 1427925) see the Securities and Exchange Commission (SEC) website.